These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 29899322)

  • 1. Cervical Cancer Cell Growth, Drug Resistance, and Epithelial-Mesenchymal Transition Are Suppressed by y-Secretase Inhibitor RO4929097.
    Wang L; Dai G; Yang J; Wu W; Zhang W
    Med Sci Monit; 2018 Jun; 24():4046-4053. PubMed ID: 29899322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.
    Lombardo Y; Faronato M; Filipovic A; Vircillo V; Magnani L; Coombes RC
    Breast Cancer Res; 2014 Jun; 16(3):R62. PubMed ID: 24919951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
    Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
    Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. γ-Secretase inhibitor inhibits bladder cancer cell drug resistance and invasion by reducing epithelial-mesenchymal transition.
    Wang Y; Wang G; Zhang X; Zhou X; Liu Z; Huang L; Liu R; Lang B; Xu X; Liu W; Fu L; Fu B
    Mol Med Rep; 2015 Aug; 12(2):2821-7. PubMed ID: 25955824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [S100A7 promotes the metastasis and epithelial-mesenchymal transition on HeLa and CaSki cells].
    Tian T; Hua Z; Wang LZ; Wang XY; Chen HY; Liu ZH; Cui ZM
    Zhonghua Fu Chan Ke Za Zhi; 2018 Feb; 53(2):99-105. PubMed ID: 29534378
    [No Abstract]   [Full Text] [Related]  

  • 7. The novel gamma secretase inhibitor RO4929097 reduces the tumor initiating potential of melanoma.
    Huynh C; Poliseno L; Segura MF; Medicherla R; Haimovic A; Menendez S; Shang S; Pavlick A; Shao Y; Darvishian F; Boylan JF; Osman I; Hernando E
    PLoS One; 2011; 6(9):e25264. PubMed ID: 21980408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells.
    Debeb BG; Cohen EN; Boley K; Freiter EM; Li L; Robertson FM; Reuben JM; Cristofanilli M; Buchholz TA; Woodward WA
    Breast Cancer Res Treat; 2012 Jul; 134(2):495-510. PubMed ID: 22547109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma secretase inhibitor impairs epithelial-to-mesenchymal transition induced by TGF-β in ovarian tumor cell lines.
    Pazos MC; Abramovich D; Bechis A; Accialini P; Parborell F; Tesone M; Irusta G
    Mol Cell Endocrinol; 2017 Jan; 440():125-137. PubMed ID: 27908834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN regulates sensitivity of melanoma cells to RO4929097, the γ-secretase inhibitor.
    Nair JS; Sheikh T; Ho AL; Schwartz GK
    Anticancer Res; 2013 Apr; 33(4):1307-16. PubMed ID: 23564767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cell specific molecule 1 promotes epithelial-mesenchymal transition of cervical cancer via the E-box binding homeobox 1.
    Qi J; Li J; Zhu X; Zhao S
    PLoS One; 2024; 19(7):e0304597. PubMed ID: 38954708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF-β- induced Epithelial-to-mesenchymal transition via ROS/Smad signaling in human cervical cancer cells.
    Panji M; Behmard V; Zare Z; Malekpour M; Nejadbiglari H; Yavari S; Nayerpour Dizaj T; Safaeian A; Maleki N; Abbasi M; Abazari O; Shabanzadeh M; Khanicheragh P
    Gene; 2021 Aug; 794():145774. PubMed ID: 34126197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway.
    Zang MD; Hu L; Fan ZY; Wang HX; Zhu ZL; Cao S; Wu XY; Li JF; Su LP; Li C; Zhu ZG; Yan M; Liu BY
    J Transl Med; 2017 Feb; 15(1):52. PubMed ID: 28241766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells.
    Han B; Liu SH; Guo WD; Zhang B; Wang JP; Cao YK; Liu J
    World J Gastroenterol; 2015 Sep; 21(33):9727-35. PubMed ID: 26361419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.
    Palagani V; El Khatib M; Kossatz U; Bozko P; Müller MR; Manns MP; Krech T; Malek NP; Plentz RR
    PLoS One; 2012; 7(10):e46514. PubMed ID: 23094026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44
    Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR
    Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TMEM45A Affects Proliferation, Apoptosis, Epithelial-Mesenchymal Transition, Migration, Invasion and Cisplatin Resistance of HPV-Positive Cervical Cancer Cell Lines.
    Liu Y; Liu L; Mou ZX
    Biochem Genet; 2022 Feb; 60(1):173-190. PubMed ID: 34143331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties.
    Luistro L; He W; Smith M; Packman K; Vilenchik M; Carvajal D; Roberts J; Cai J; Berkofsky-Fessler W; Hilton H; Linn M; Flohr A; Jakob-Røtne R; Jacobsen H; Glenn K; Heimbrook D; Boylan JF
    Cancer Res; 2009 Oct; 69(19):7672-80. PubMed ID: 19773430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-myeloma effect of pharmacological inhibition of Notch/gamma-secretase with RO4929097 is mediated by modulation of tumor microenvironment.
    Pisklakova A; Grigson E; Ozerova M; Chen F; Sullivan DM; Nefedova Y
    Cancer Biol Ther; 2016 May; 17(5):477-85. PubMed ID: 26934342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.